BRIEF-Kalytera Announces Issuance Of Patent Covering The Use Of CBD For The Treatment Of Severe And Refractory Graft Versus Host Disease

1 分钟阅读

April 19 (Reuters) - Kalytera Therapeutics Inc:

* KALYTERA ANNOUNCES ISSUANCE OF PATENT COVERING THE USE OF CBD FOR THE TREATMENT OF SEVERE AND REFRACTORY GRAFT VERSUS HOST DISEASE

* KALYTERA THERAPEUTICS INC - KALYTERA ALSO EXPECTS TO INITIATE AN ADDITIONAL PHASE 2 CLINICAL STUDY IN TREATMENT OF GVHD LATER THIS YEAR Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)